Sera Prognostics, Inc. - Class A Common Stock (SERA)

Sera Prognostics Inc is a biotechnology company focused on advancing maternal and fetal health through innovative diagnostic solutions

The company primarily develops predictive tests that aim to assess the risk of pregnancy complications, enabling healthcare providers to offer personalized care and interventions for expectant mothers and their babies. By harnessing advanced biomarker analysis and machine learning technologies, Sera Prognostics seeks to improve pregnancy outcomes and reduce healthcare costs associated with managing high-risk pregnancies. Their commitment to research and collaboration with healthcare professionals highlights their dedication to enhancing the overall well-being of mothers and infants.